Published in Blood Weekly, October 4th, 2001
UAMS's Myeloma Institute for Research and Therapy will focus exclusively on pioneering research and developing innovative treatment. "This unique institute will provide advanced medical training for oncologists with a specialization in multiple myeloma, conduct pioneering research in this field, and offer state-of-the-art treatment for patients from around the world," said Dodd Wilson, MD, UAMS Chancellor.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.